Assistant Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Infectious Disease
Dr. Diana F. Florescu, MD
|
|
Give Review
Diana F. Florescu practices Infectious Disease. Diana Florescu is also a published MD. He has 52 publication published. The most recent publication is: Colistin, an Old Drug in a New Territory, Solid Organ Transplantation. Diana Florescu is registered with Medicare and accepts Medicare payments.
Publications
- Reply to Thomason et al and Bahr et al.
- A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
- Is Bacteremic Sepsis Associated with Higher Mortality in Transplant Recipients than in Non-Transplant Patients? A Matched Case-Control Propensity-Adjusted Study.
- Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
- Does increasing immunoglobulin levels impact survival in solid organ transplant recipients with hypogammaglobulinemia?
- Adenovirus: current epidemiology and emerging approaches to prevention and treatment.
- Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis.
- Cidofovir in Pediatric Solid Organ Transplant Recipients: University of Nebraska Experience.
- A Direct and Indirect Comparison Meta-analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplantation.
- The complex link between influenza and severe sepsis.
- An International Survey of Cytomegalovirus Prevention and Treatment Practices in Intestinal Transplantation.
- What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta-Analysis.
- Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis.
- Opportunistic viral infections in intestinal transplantation.
- What do we know about adenovirus in renal transplantation?
- Adenovirus in solid organ transplantation.
- Cytomegalovirus reactivation and colitis after left ventricular assist device placement.
- Can we predict cytomegalovirus reactivation in critically ill patients?*.
- Risk of cytomegalovirus disease in high-risk liver recipients on valganciclovir prophylaxis: A systematic review and meta-analysis.
- Staphylococcus aureus infections after liver transplantation.
- Incidence, risk factors, and outcomes associated with cytomegalovirus disease in small bowel transplant recipients.
- Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin.
- Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
- Bloodstream Infections during the First Year after Pediatric Small Bowel Transplantation.
- Pediococcus acidilactici Endocarditis Successfully Treated with Daptomycin.
- Should Multivisceral Transplantation Be Considered in Patients Colonized with Multidrug-Resistant Pseudomonas aeruginosa?
- Risk Factors for Systemic Candida Infections in Pediatric Small Bowel Transplant Recipients.
- Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients.
- Risk Factors and Outcomes of Staphylococcus aureus Infections After Small Bowel and Multivisceral Transplantation.
- Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?
- Cytomegalovirus Infections in Non-immunocompromised and Immunocompromised Patients in the Intensive Care Unit.
- Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
- Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis.
- Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines.
- The importance of detecting cytomegalovirus infections in studies evaluating new therapies for severe sepsis.
- Adenovirus infections in pediatric small bowel transplant recipients.
- Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit.
- Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin.
- Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature.
- Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
- Enterococcus pneumonia complicated with empyema and lung abscess in an HIV-positive patient. Case report and review of the literature.
- Incidence and outcome of fungal infections in pediatric small bowel transplant recipients.
- Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.
- IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis.
- Clostridium difficile and cytomegalovirus colitis co-infection: search for the hidden ''bug''.
- Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review.
- Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors.
- Splenic infarction in human babesiosis: two cases and discussion.
- Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
- Adenovirus infections in heart transplantation.
- Colistin, an Old Drug in a New Territory, Solid Organ Transplantation.
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Accord
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Nebraska PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
St Luke's-Roosevelt Hospital Center -
Carol Davila University of Medicine and Pharmacy
Drug Facts
| NPI NUMBER | 1063464980 | |
| NPPES Provider LastName | FLORESCU | |
| NPPES Provider FirstName | DIANA | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063464980 |
| Last Name Of The Provider | FLORESCU |
| First Name Of The Provider | DIANA |
| View All |
Similar Doctors
|
Dr. Marvin J. Bittner, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gary L. Gorby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea D. Green Hines, MD |
|
|
Dr. Angela L. Hewlett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison G. Freifeld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Horne, MD |
|
|
Dr. Rudolf J. Kotula, MD
This Doctor is OpenDoctor Recommended.
|